{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:37:00Z","timestamp":1790627820964,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ophtha.2011.04.035","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T01:47:04Z","timestamp":1311385624000},"page":"2120-2127","source":"Crossref","is-referenced-by-count":26,"title":["Safety and Efficacy of Bromfenac Ophthalmic Solution (Bromday) Dosed Once Daily for Postoperative Ocular Inflammation and Pain"],"prefix":"10.1016","volume":"118","clinical-trial-number":[{"clinical-trial-number":"nct00585975","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00703781","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00704418","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00853970","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Bonnie A.","family":"Henderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny L.","family":"Gayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Gow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Klier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2011.04.035_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archopht.122.4.487","article-title":"Prevalence of cataract and pseudophakia\/aphakia among adults in the United States","volume":"122","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.04.035_bib2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1185\/030079905X50651","article-title":"Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care","volume":"21","author":"O'Brien","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ophtha.2011.04.035_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02713680490513164","article-title":"Involvement of cyclooxygenase-2 in rat models of conjunctivitis","volume":"29","author":"Oka","year":"2004","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2011.04.035_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2001-15886","article-title":"Non-steroidal anti-inflammatory drugs and ocular inflammation [in French]","volume":"218","author":"Guex-Crosier","year":"2001","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ophtha.2011.04.035_bib5","first-page":"637","article-title":"Prostaglandins, nonsteroidal anti-inflammatory agents and eye disease","volume":"74","author":"Podos","year":"1976","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2011.04.035_bib6","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/jm00377a001","article-title":"Antiinflammatory agents","volume":"27","author":"Walsh","year":"1984","journal-title":"J Med Chem"},{"key":"10.1016\/j.ophtha.2011.04.035_bib7","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"141","article-title":"Muscarinic receptor agonists and antagonists","author":"Brown","year":"1996"},{"key":"10.1016\/j.ophtha.2011.04.035_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/jop.2007.0082","article-title":"24-hour evaluation of the ocular distribution of (14)C-labeled bromfenac following topical instillation into the eyes of New Zealand White rabbits","volume":"24","author":"Baklayan","year":"2008","journal-title":"J Ocular Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2011.04.035_bib9","series-title":"Bronuck [package insert]","year":"2009"},{"key":"10.1016\/j.ophtha.2011.04.035_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.iio.0000212134.83513.11","article-title":"Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug","volume":"46","author":"Donnenfeld","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2011.04.035_bib11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1586\/17469899.2.4.543","article-title":"Pharmacology, clinical efficacy and safety of bromfenac ophthalmic solution","volume":"2","author":"Fujishima","year":"2007","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.04.035_bib12","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1517\/14656560903188425","article-title":"Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent","volume":"10","author":"Jones","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ophtha.2011.04.035_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2147\/OPTH.S4806","article-title":"Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution","volume":"3","author":"Cho","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.04.035_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/jop.2007.0040","article-title":"The systemic safety of bromfenac ophthalmic solution 0.09%","volume":"23","author":"Stewart","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2011.04.035_bib15","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.ophtha.2006.12.029","article-title":"Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation","volume":"114","author":"Donnenfeld","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.04.035_bib16","series-title":"Xibrom [package insert]","year":"2010"},{"key":"10.1016\/j.ophtha.2011.04.035_bib17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/jop.2007.0132","article-title":"Ocular pharmacokinetics of a single dose of bromfenac sodium ophthalmic solution 0.1% in human aqueous humor","volume":"24","author":"Miyake","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2011.04.035_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1248\/yakushi.121.799","article-title":"Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions [in Japanese]","volume":"121","author":"Ikeda","year":"2001","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ophtha.2011.04.035_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajo.2007.06.012","article-title":"Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use","volume":"144","author":"Robin","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.04.035_bib20","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0161-6420(03)01004-2","article-title":"Safe and effective","volume":"110","author":"Schachat","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2011.04.035_bib21","series-title":"Bromday [package insert]","year":"2010"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011004222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011004222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T11:57:57Z","timestamp":1543665477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642011004222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0161642011004222"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.04.035","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}